Medindia
Medindia LOGIN REGISTER
Advertisement

Phlo Affiliate Names Director Of Marketing

Thursday, November 8, 2007 General News
Advertisement
JACKSONVILLE, Fla., Nov. 7 An affiliate of PhloCorporation (OTC: PHLC) (the "Company") announced today that it has hired DanReynolds as its Director of Marketing. Mr. Reynolds is a marketing andcommunications expert with nearly 30 years of experience in the United Statesand Canada. Mr. Reynolds will support the branding, marketing, andcommunications functions of the Company, headed by Rudy Prajza, ChiefMarketing Officer.
Advertisement

Mr. Reynolds' professional experience includes work in over 14 industriessuch as food and beverages, financial services, hospitality,telecommunications, automobiles, health and beauty aids, and petroleum. Hisdirect working experience includes such internationally-recognizedorganizations as Gillette, Subway, Sears, Royal Bank, BMW, Honda, theGovernment of Canada, Brita (water purifiers), and Petro-Canada, among others.
Advertisement

Mr. Reynolds has worked with a number of marketing communicationscompanies including Saatchi & Saatchi, DMB&B, Foote, Cone & Belding, andMacLaren-McCann Advertising.

AQUISS(TM) features the Company's Instant Nano Hydration and Cell Armortechnologies, providing instant, direct delivery of rehydration and cell-repair-and-protection payloads into the bloodstream beginning through themembranes of the mouth. These Instant Nano Hydration and Cell Armortechnologies help provide sustained wellness necessary for life's performancesand vigorous longevity. In addition, the Company's nano-encapsulationtechnology prevents the destruction of its active payloads in the stomach.

Phlo is a biotechnology company and a manufacturer and marketer ofproducts (primarily liquids) containing patented and patent-pendingbiotechnologies. Phlo is focusing its technology generation and acquisitionefforts on those technologies related to enhancing cognition and personalperformance, reducing the effects of aging, and preventing or amelioratingcancer.

Certain statements made herein that are not historical constitute"forward-looking" statements within the meaning of the Private LitigationReform Act of 1995 and may contain words such as "anticipate," "believe,""expect," "future," "may," "will," "should," "plan," "projected," "intend,"and similar expressions to identify such forward-looking statements. Suchstatements are based on a number of assumptions and on information andestimates supplied to Phlo Corporation by sources currently available to it.Such assumptions and estimates are subject to uncertainties, contingencies,and other factors, many of which are beyond Phlo Corporation's control.Actual results may differ materially from the statements set forth above.

SOURCE Phlo Corporation
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close